Skip to main content

Part of cannabis and investing

Vic Neufeld is seen at Aphria's greenhouse in Leamington, Ont., in 2014.

GEOFF ROBINS

Vic Neufeld will step down as chief executive officer of Aphria Inc., sources say, when the cannabis grower finds a replacement for him, the company is expected to announce on Friday.

Aphria, which has been facing questions about its deal-making and a slumping stock price, is expected to say that it is beginning a search for someone to replace Mr. Neufeld in the top job, which he has held since 2014. The company, one of the largest Canadian marijuana producers, is also set to release its quarterly results on Friday.

The company, based in Leamington, Ont., is hoping to attract a prominent executive with global know-how to step into Mr. Neufeld’s job – and not necessarily someone from the cannabis sector, said a source familiar with the situation. The individual was granted anonymity by The Globe and Mail because the person was not authorized to speak publicly about the matter. The company has not set a date for the departure of Mr. Neufeld, who will also step down as a member of Aphria’s board of directors, sources said.

Story continues below advertisement

Aphria and Mr. Neufeld didn't respond Thursday night to requests for comment.

Also: Aphria confirms CEO, co-founder to exit embattled cannabis producer

The expected announcement of his departure comes weeks after Aphria was targeted by two short-sellers in a report that criticized the company’s nearly $300-million stock deal to acquire marijuana assets in Colombia, Argentina and Jamaica. The report provided photographs and documents that suggested the assets are not significant and are worth a fraction of that amount.

Aphria has disputed the report but created an independent committee of the board to look into those allegations. Last month, Mr. Neufeld stepped aside as chair to make way for an independent director, Irwin Simon, in the post.

Aphria also came under fire early last year after The Globe reported that Mr. Neufeld, other directors and its chief financial officer personally owned undisclosed shares in Nuuvera Inc. when Aphria acquired the company for $425-million. Aphria said these investments were immaterial and not required to be disclosed by corporate law.

Mr. Neufeld helped grow Aphria to one of Canada’s largest licensed producers of cannabis; it has a stock-market capitalization of about $2-billion. Before joining Aphria, he was CEO at Jamieson Laboratories Ltd. for 21 years, where he led the vitamin company from $20-million in annual sales to $250-million. Before that, he spent 15 years as a partner at Ernst & Young.

Aphria is also expected to announce on Friday that co-founder Cole Cacciavillani, an industrial engineer and greenhouse operator in charge of Aphria’s growing operations, will also be leaving the company, sources said. Aphria and Mr. Cacciavillani didn’t respond Thursday night to requests for comment. ​

Available now: Cannabis Professional, the authoritative e-mail newsletter tailored specifically for professionals in the rapidly evolving cannabis industry. Subscribe now.

Report an error Editorial code of conduct
Tickers mentioned in this story
Unchecking box will stop auto data updates
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

Cannabis pro newsletter